Gilead Sciences Inc. (NASDAQ: GILD) was reiterated as Sell with a $70 price target (versus a $74.76 close) at SunTrust Robinson Humphrey. The firm noted that it is reasonable there could be commercial revenues from remdesivir in the third and fourth quarters, but it is not set in stone under a post-donation model.
Hain Celestial Group Inc. (NASDAQ: HAIN) was raised to Outperform from Market Perform with a $36 price target (versus a $29.13 close) at Bernstein.
Hess Corp. (NYSE: HES) was reiterated as Overweight and the price target was raised to $49 from $48 (versus a $49.11 close) at Morgan Stanley.
Intuit Inc. (NASDAQ: INTU) was reiterated as Overweight and the price target was raised to $315 from $285 (versus a $290.37 close) at KeyBanc Capital markets.
JD.com Inc. (NASDAQ: JD) was reiterated as Buy and its price target was raised to $64 from $54 (versus a $55.53 close, after a 9.2% gain) at Nomura/Instinet.
Lockheed Martin Corp. (NYSE: LMT) was started with a Buy rating and a $435 price target (versus a $377.54 close) at Seaport Global.
Lululemon Athletica Inc. (NASDAQ: LULU) was reiterated as Buy and its price target was raised to $290 from $256 (versus a $255.65 close) at B. Riley FBR.
Mallinckrodt PLC (NYSE: MNK) was downgraded to Underweight from Neutral at JPMorgan.
Marathon Oil Corp. (NYSE: MRO) was downgraded to Underweight from Equal Weight at Morgan Stanley.
Moody’s Corp. (NYSE: MCO) was started with an Outperform rating and a $290 price target (versus $259.81 prior close) at Oppenheimer.
Newmont Corp. (NYSE: NEM) was reiterated as Buy and its price target was raised to $97 from $96 (versus a $66.26 close) at B. Riley FBR.
Royal Gold Inc. (NASDAQ: RGLD) was reiterated as Buy and the price target was raised to $151 from $150 (versus a $134.28 close) at B. Riley FBR.
Southern Copper Corp. (NYSE: SCCO) was reiterated as Buy and its price target was raised to $40 from $38 (versus a $35.63 close) at UBS.
S&P Global Inc. (NYSE: SPGI) was started with an Outperform rating and a $340 price target (versus a $311.63 close) at Oppenheimer.
TherapeuticsMD Inc. (NASDAQ: TXMD) was downgraded to Neutral from Overweight at JPMorgan.
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) was named as the Bull of the Day at Zacks, which said that while COVID-19 interrupts clinical trials, the champ of cystic fibrosis is about to repeat another year of 37% revenue growth. Shares most recently closed at $284.13, with a consensus price target of $283.91.
While oil has had a huge bounce off the April lows, many of the top companies in the sector have not. Four top energy stocks to buy that pay dividends make good sense to BofA Securities analysts for investors looking to add positions in a down and out sector.
Monday’s top analyst upgrades and downgrades included Apple, Best Buy, Cinemark, Co-Diagnostics, DraftKings, Energizer, Novavax, Nvidia, Palo Alto Networks and Petrobras.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.